ArticleTherapeutic advances in neurological disorders2026
Efficacy and safety of interleukin-6 receptor inhibitors in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A systematic review and meta-analysis.
Aasim Ali et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.